June 2, 2020

We are part of the Mass Challenge 2020 Life Science Cohort

We are pleased to announce that Vatic (formerly My110) have been selected to be on the Boston based Mass Challenge 2020 cohort of innovative companies. Their support will allow us to bring our rapid health monitoring solutions to market sooner.

You can find out more about the other companies on the cohort and the programme itself here.

Find out more

Register interest to find out more about our saliva based COVID-19 infectiousness test.

view our privacy policy here
Had COVID - 19 symptoms in the last 2 days? Apply here to help us make testing accessible to all.